Glycaemic outcomes in adults with type 1 diabetes transitioning towards advanced automated insulin delivery systems - a real-world analysis at a Swiss tertiary centre

被引:1
|
作者
Lehmann, Vera [1 ]
Noti, Franco [1 ]
Laimer, Markus [1 ]
Stettler, Christoph [1 ]
Zuger, Thomas [1 ,2 ]
机构
[1] Univ Bern, Bern Univ Hosp, Inselspital, Dept Diabet Endocrinol Nutr Med & Metab, CH-3010 Bern, Switzerland
[2] Kantonsspital Olten, Dept Diabet Endocrinol & Metab Dis, Olten, Switzerland
关键词
HYBRID CLOSED-LOOP;
D O I
10.57187/s.3501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIMS OF THE STUDY: To assess glucose levels in adults with diabetes at a Swiss tertiary hospital when transitioning from insulin delivery with a sensor-augmented pump with (predictive) low-glucose suspend ([P]LGS) to a hybrid-closed loop (HCL) and from a HCL to an advanced hybrid-closed loop (AHCL). METHODS: Continuous glucose monitoring data for 44 adults with type 1 diabetes transitioning from (P)LGS to hybrid-closed loop and from hybrid-closed loop to advanced hybrid-closed loop were analysed, including the percentage of time spent within, below, and above glucose ranges. In addition, a subgroup analysis (n = 14) of individuals undergoing both transitions was performed. RESULTS: The transition from a (P)LGS to a hybrid-closed loop was associated with increased time in range (6.6% [2.6%-12.7%], p <0.001) and decreased time above range (5.6% [2.3%-12.7%], p <0.001). The transition from a hybrid-closed loop to an advanced hybrid-closed loop was associated with increased time in range (1.6% [-0.5%-4.5%], p = 0.046) and decreased time above range (1.5% [-1.8%-5.6%], p = 0.050). Both transitions did not change the time below range. In the subgroup analysis ([P]LGS. HCL. AHCL), the time in range increased from 69.4% (50.3%-79.2%) to 76.5% (65.3%-81.3%) and 78.7% (69.7%-85.8%), respectively (p <0.001). CONCLUSIONS: Glucose levels significantly improved when transitioning from a (P)LGS to a hybrid-closed loop. Glucose levels improved further when switching from a hybrid-closed loop to an advanced hybrid-closed loop. However, the added benefit of an advanced hybrid-closed loop was comparably smaller. This pattern was also reflected in the subgroup analysis.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis
    Yang, Qin
    Zeng, Baoqi
    Hao, Jiayi
    Yang, Qingqing
    Sun, Feng
    DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3753 - 3763
  • [3] Real-world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial
    Kubilay, Erin
    Trawley, Steven
    Ward, Glenn M.
    Fourlanos, Spiros
    Colman, Peter G.
    McAuley, Sybil A.
    DIABETIC MEDICINE, 2024, 41 (04)
  • [4] Automated insulin delivery systems in adults with type 1 diabetes: A real game changer?
    Bem, R.
    Vavra, D.
    Sochorova, K.
    Mullerova, M.
    Haluzik, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S394 - S394
  • [5] Automated insulin delivery among adults with type 1 diabetes for up to 2 years: a real-world, multicentre study
    Donaldson, Laura E.
    Fourlanos, Spiros
    Vogrin, Sara
    MacIsaac, Richard J.
    Colman, Peter G.
    McAuley, Sybil A.
    INTERNAL MEDICINE JOURNAL, 2024, 54 (01) : 121 - 128
  • [6] REAL-WORLD EVIDENCE OF AUTOMATED INSULIN DELIVERY (AID) USE IN A LARGE SAMPLE OF OLDER ADULTS WITH TYPE 1 DIABETES
    Stumpf, M.
    Brown, S.
    Fabris, C.
    Kovatchev, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A140 - A141
  • [7] Real-world glycaemic outcomes of &gt;12,200 adults with type 1 diabetes using the Omnipod® 5 Automated Insulin Delivery (AID) system with cloud-based data management
    Wilmot, E. G.
    Lal, R. A.
    Aleppo, G.
    Huyett, L. M.
    Snow, K.
    Mendez, J. J.
    Hadjiyianni, I.
    Ly, T. T.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S119 - S120
  • [8] Recently diagnosed with type 1 diabetes: glycaemic outcomes with the Omnipod® Automated Insulin Delivery System
    Forlenza, G. P.
    DeSalvo, D. J.
    Bode, B. W.
    Criego, A. B.
    Brown, S. A.
    Schoelwer, M. J.
    Mehta, S. N.
    Laffel, L. M.
    MacLeish, S. A.
    Huyett, L. M.
    Boyd, J.
    Gurlin, R. E.
    Ly, T. T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S345 - S345
  • [9] Type 1 diabetes: analysis of real-world insulin injection patterns
    Catrina, S.
    Hartvig, N.
    Kaas, A.
    Moller, J.
    Mardby, A. -C.
    Jendle, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S378 - S378
  • [10] Real-world analysis of percent of patients with type 2 diabetes achieving glycaemic goal with insulin glargine
    Misurski, D.
    Schroeder, B.
    Wade, R.
    Quimbo, R.
    Nielsen, L.
    Fabunmi, R.
    Wintle, M.
    DIABETOLOGIA, 2008, 51 : S386 - S387